A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.292 SEK 0.34% Market Closed
Market Cap: 407.4m SEK
Have any thoughts about
Active Biotech AB publ?
Write Note

Active Biotech AB publ
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Active Biotech AB publ
Cash Equivalents Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Active Biotech AB publ
STO:ACTI
Cash Equivalents
kr6.2m
CAGR 3-Years
-55%
CAGR 5-Years
-38%
CAGR 10-Years
-28%
Biogaia AB
STO:BIOG B
Cash Equivalents
kr1.5B
CAGR 3-Years
2%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cash Equivalents
kr153.2m
CAGR 3-Years
-12%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Cash Equivalents
kr925m
CAGR 3-Years
-42%
CAGR 5-Years
9%
CAGR 10-Years
23%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cash Equivalents
kr594m
CAGR 3-Years
41%
CAGR 5-Years
-11%
CAGR 10-Years
0%
BioArctic AB
STO:BIOA B
Cash Equivalents
kr611.6m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
N/A

See Also

What is Active Biotech AB publ's Cash Equivalents?
Cash Equivalents
6.2m SEK

Based on the financial report for Sep 30, 2024, Active Biotech AB publ's Cash Equivalents amounts to 6.2m SEK.

What is Active Biotech AB publ's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-28%

Over the last year, the Cash Equivalents growth was 11%. The average annual Cash Equivalents growth rates for Active Biotech AB publ have been -55% over the past three years , -38% over the past five years , and -28% over the past ten years .

Back to Top